Chemoprevention of gastric cancer by celecoxib in rats

Gut

Volumn 53, Issue 2, 2004, Pages 195-200

  Hu, P J ^b   Yu, J ^a   Zeng, Z R ^b   Leung, W K ^a   Lin, H L ^b   Tang, B D ^b   Bai, A H C ^a   Sung, J J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DRINKING WATER; INDOMETACIN; METHYLNITRONITROSOGUANIDINE; PROSTAGLANDIN E2; SODIUM CHLORIDE;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE MODEL; EVALUATION; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH TUMOR; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUG ADMINISTRATION SCHEDULE; INDOMETHACIN; ISOENZYMES; MALE; METHYLNITRONITROSOGUANIDINE; MODELS, ANIMAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, WISTAR; SODIUM CHLORIDE; STOMACH NEOPLASMS; SULFONAMIDES;

EID: 1642451874     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.021477     Document Type: Article

References (39)

1. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
2. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
3. Sung JJY, Lin SR, Ching JYL, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study Gastroenterology 2000;119:7-14.
4. Correa P, Fontham ETH, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter therapy. J Natl Cancer Inst 2000;92:1881-8.
5. Sturmer T, Glynn RJ, Lee IM, et al. Aspirin use and colorectal cancer: post-trial follow-up data from teh Physician's Health Study. Ann Intern Med 1998;128:713-20.
6. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001;1:11-21.
7. Steinbach G, Lynch PM, Phlips RKS, et al. The effects of celecoxib, a cyclooxygenase 2 inhibitor in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
8. Chan FK, To KF, Ng YP, et al. Expression and cellular localization of COX-1 and -2 in Helicobacter pylori gastritis. Aliment Pharmacol Ther 2001;15:187-93.
9. Ristimaki A, Honkanen N, Jankala H, et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57:1276-80.
10. Yamamoto H, Itoh F, Fukushima H, et al. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int J Cancer 1999;84:400-3.
11. Uefuji K, Ichikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 2000;6:135-8.
12. Leung WK, To KF, Ng YP, et al. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br J Cancer 2001;84:335-9.
13. Sung JJY, Leung WK, Go MYY, et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000;157:729-35.
14. Tsuji S, Kawano S, Sawaoka H, et al. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot Essent Fatty Acids 1996;55:179-83.
15. Sawaoka H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 1998;274:G1061-7.
16. Sugimura T, Fujimura S, Baba T. Tumor production in the glandular stomach and alimentary tract of the rat by N-methyl-N′-nitro- nitrosoguanidine. Cancer Res 1970;30:455-65.
17. Tatematsu M, Takahashi M, Fukushima S, et al. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N- nitrosoguanidine or 4-nitroquinoline-1-oxide. J Natl Cancer Inst 1975;55:101-6.
18. Rao CV, Rivernson A, Simi B, et al. Chemoprevention of colon carcinogenesis by sulindac, a nosteroidal anti-inflammatory agent. Cancer Res 1995;55:1464-72.
19. Saito T, Inokuchi K, Takayama S, et al. Sequential morphological changes in N-methyl-N′-nitro-N-nitrosoguanidine carcinogenesis in the glandular stomach of rats. J Natl Cancer Inst 1970;44:769-83.
20. Matsukura N, Kawachi T, Sasajima K, et al. Induction of intestinal metaplasia in the stomachs of rats by N-methyl-N′-nitro-N- nitrosoguanidine. J Natl Cancer Inst 1978;61:141-4.
21. Ushijima T, Yamamoto M, Suzui M, et al. Chromosomal mapping of genes controlling development, histological grade, depth of invasion, and size of rat stomach carcinomas. Cancer Res 2000;60:1092-6.
22. Ohgaki H, Kawachi T, Matsukura N, et al. Genetic control of susceptibility of rats to gastric carcinoma. Cancer Res 1983;43:3663-7.
23. Loogna P, Franzen L, Sipponen P, et al. Cyclooxygenase-2 and Bcl-2 expression in the stomach mucosa of Wistar rats exposed to Helicobacter pylori, N-methyl-N′-nitro-N-nitrosoguanidine and bile. Virchows Arch 2002;441:77-84.
24. Kawamori T, Rao CV, Seibert K, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998;58:409-12.
25. Tatsuta M, Iishi H, Baba M, et al. Attenuation by genistein of sodium-chloride-enhanced gastric carcinogenesis induced by N-methyl-N′- nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 1999;80:396-9.
26. Uedo N, Tatsuta M, Baba M, et al. Inhibition by rat C-erbB-2/neu antisense oligonucleotide of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 1999;83:670-3.
27. Ikezaki S, Nishikawa A, Furukawa F, et al. Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N′-nitro- N-nitrosoguanidine and sodium chloride in rats. Anticancer Res 2001;21:3407-11.
28. Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res 2002;51:603-10.
29. Cuzzocrea S, Mazzon E, Serraino I, et al. Celecoxib, a selective cyclooxygenase-2 inhibitor reduced the severity of experimental colitis induced dinitrobenzene sulfonic acid in rats. Eur J Pharmacol 2001;431:91-102.
30. Charalambous D, Farmer C, O'Brien PE. Sulindac and indomethacin inhibit formation of aberrant crypt foci in the colons of dimethyl hydrazine treated rats. J Gastroenterol Hepatol 1996;11:88-92.
31. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cycloxoygenase-2. Nat Rev Cancer 2001;1:11-21.
32. Chan TA. Non-steroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol 2002;3:166-74.
33. Carlton PS, Gopalakrishnan R, Gupta A, et al. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus. Cancer Res 2002;62:4376-82.
34. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891-9.
35. Karin M, Cao Y, Greten FR, et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301.
36. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998;396:77-80.
37. Lai GH, Zhang Z, Sirica AE. Celecoxib acts in a cyclooxygenase-2- independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and -3. Mol Cancer Ther 2003;2:265-71.
38. Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642-8.
39. Takahashi S, Fujita T, Yamamoto A. Role of cyclooxygenase-2 in Helicobacter pylori-induced gastritis in Mongolian gerbils. Am J Physiol Gastrointest Liver Physiol 2000;279:G791-8.